selfotel has been researched along with Substance Withdrawal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hogg, JE; Hutson, PH | 1 |
| Bespalov, AIu; Zvartau, EE | 1 |
2 other study(ies) available for selfotel and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Binding, Competitive; Clonidine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Male; Microdialysis; Morphine Dependence; Naltrexone; Narcotic Antagonists; Pipecolic Acids; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 1997 |
[NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics].
Topics: Animals; Conditioning, Classical; Discrimination Learning; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Mice; Motivation; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pipecolic Acids; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Recurrence; Substance Withdrawal Syndrome | 1998 |